Pregnenolone 16α-carbonitrile ameliorates concanavalin A-induced liver injury in mice independent of the nuclear receptor PXR activation

Susumu Kodama, Takuto Shimura, Hideaki Kuribayashi, Taiki Abe, Kouichi Yoshinari

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

The pregnane X receptor (PXR) is well-known as a key regulator of drug/xenobiotic clearance. Upon activation by ligand, PXR transcriptionally upregulates the expression of drug-metabolizing enzymes and drug transporters. Recent studies have revealed that PXR also plays a role in regulating immune/inflammatory responses. Specific PXR activators, including synthetic ligands and phytochemicals, have been shown to ameliorate chemically induced colitis in mice. In this study, we investigated an anti-inflammatory effect of pregnenolone 16α-carbonitrile (PCN), a prototypical activator for rodent PXR, in concanavalin A (Con A)-induced liver injury, a model of immune-mediated liver injury, using wild-type and Pxr−/− mice. Unexpectedly, pretreatment with PCN significantly ameliorated Con A-induced liver injury in not only wild-type but Pxr−/− mice as well, accompanied with lowered plasma ALT levels and histological improvements. Pretreatment with PCN was found to significantly repress the induction of Cxcl2 and Ccl2 mRNA expression and neutrophil infiltration into the liver of both wild-type and Pxr−/− mice at the early time point of Con A-induced liver injury. Our results indicate that PCN has unexpected immunosuppressive activity independent of PXR activation to protect mice from immune-mediated liver injury induced by Con A.

Original languageEnglish
Pages (from-to)58-65
Number of pages8
JournalToxicology Letters
Volume271
DOIs
Publication statusPublished - Apr 5 2017
Externally publishedYes

Fingerprint

Pregnenolone Carbonitrile
Cytoplasmic and Nuclear Receptors
Concanavalin A
Liver
Chemical activation
Wounds and Injuries
Pharmaceutical Preparations
Ligands
Neutrophil Infiltration
Phytochemicals
Xenobiotics
Colitis
Immunosuppressive Agents
Infiltration
pregnane X receptor
16-pregnolone
Rodentia
Anti-Inflammatory Agents
Up-Regulation
Plasmas

Keywords

  • Immune-mediated liver injury
  • Pregnane X receptor
  • Pregnenolone 16α-carbonitrile

ASJC Scopus subject areas

  • Toxicology

Cite this

Pregnenolone 16α-carbonitrile ameliorates concanavalin A-induced liver injury in mice independent of the nuclear receptor PXR activation. / Kodama, Susumu; Shimura, Takuto; Kuribayashi, Hideaki; Abe, Taiki; Yoshinari, Kouichi.

In: Toxicology Letters, Vol. 271, 05.04.2017, p. 58-65.

Research output: Contribution to journalArticle

Kodama, Susumu ; Shimura, Takuto ; Kuribayashi, Hideaki ; Abe, Taiki ; Yoshinari, Kouichi. / Pregnenolone 16α-carbonitrile ameliorates concanavalin A-induced liver injury in mice independent of the nuclear receptor PXR activation. In: Toxicology Letters. 2017 ; Vol. 271. pp. 58-65.
@article{fb3756b4bf4349ec9625a041e43e9c76,
title = "Pregnenolone 16α-carbonitrile ameliorates concanavalin A-induced liver injury in mice independent of the nuclear receptor PXR activation",
abstract = "The pregnane X receptor (PXR) is well-known as a key regulator of drug/xenobiotic clearance. Upon activation by ligand, PXR transcriptionally upregulates the expression of drug-metabolizing enzymes and drug transporters. Recent studies have revealed that PXR also plays a role in regulating immune/inflammatory responses. Specific PXR activators, including synthetic ligands and phytochemicals, have been shown to ameliorate chemically induced colitis in mice. In this study, we investigated an anti-inflammatory effect of pregnenolone 16α-carbonitrile (PCN), a prototypical activator for rodent PXR, in concanavalin A (Con A)-induced liver injury, a model of immune-mediated liver injury, using wild-type and Pxr−/− mice. Unexpectedly, pretreatment with PCN significantly ameliorated Con A-induced liver injury in not only wild-type but Pxr−/− mice as well, accompanied with lowered plasma ALT levels and histological improvements. Pretreatment with PCN was found to significantly repress the induction of Cxcl2 and Ccl2 mRNA expression and neutrophil infiltration into the liver of both wild-type and Pxr−/− mice at the early time point of Con A-induced liver injury. Our results indicate that PCN has unexpected immunosuppressive activity independent of PXR activation to protect mice from immune-mediated liver injury induced by Con A.",
keywords = "Immune-mediated liver injury, Pregnane X receptor, Pregnenolone 16α-carbonitrile",
author = "Susumu Kodama and Takuto Shimura and Hideaki Kuribayashi and Taiki Abe and Kouichi Yoshinari",
year = "2017",
month = "4",
day = "5",
doi = "10.1016/j.toxlet.2017.02.018",
language = "English",
volume = "271",
pages = "58--65",
journal = "Toxicology Letters",
issn = "0378-4274",
publisher = "Elsevier BV",

}

TY - JOUR

T1 - Pregnenolone 16α-carbonitrile ameliorates concanavalin A-induced liver injury in mice independent of the nuclear receptor PXR activation

AU - Kodama, Susumu

AU - Shimura, Takuto

AU - Kuribayashi, Hideaki

AU - Abe, Taiki

AU - Yoshinari, Kouichi

PY - 2017/4/5

Y1 - 2017/4/5

N2 - The pregnane X receptor (PXR) is well-known as a key regulator of drug/xenobiotic clearance. Upon activation by ligand, PXR transcriptionally upregulates the expression of drug-metabolizing enzymes and drug transporters. Recent studies have revealed that PXR also plays a role in regulating immune/inflammatory responses. Specific PXR activators, including synthetic ligands and phytochemicals, have been shown to ameliorate chemically induced colitis in mice. In this study, we investigated an anti-inflammatory effect of pregnenolone 16α-carbonitrile (PCN), a prototypical activator for rodent PXR, in concanavalin A (Con A)-induced liver injury, a model of immune-mediated liver injury, using wild-type and Pxr−/− mice. Unexpectedly, pretreatment with PCN significantly ameliorated Con A-induced liver injury in not only wild-type but Pxr−/− mice as well, accompanied with lowered plasma ALT levels and histological improvements. Pretreatment with PCN was found to significantly repress the induction of Cxcl2 and Ccl2 mRNA expression and neutrophil infiltration into the liver of both wild-type and Pxr−/− mice at the early time point of Con A-induced liver injury. Our results indicate that PCN has unexpected immunosuppressive activity independent of PXR activation to protect mice from immune-mediated liver injury induced by Con A.

AB - The pregnane X receptor (PXR) is well-known as a key regulator of drug/xenobiotic clearance. Upon activation by ligand, PXR transcriptionally upregulates the expression of drug-metabolizing enzymes and drug transporters. Recent studies have revealed that PXR also plays a role in regulating immune/inflammatory responses. Specific PXR activators, including synthetic ligands and phytochemicals, have been shown to ameliorate chemically induced colitis in mice. In this study, we investigated an anti-inflammatory effect of pregnenolone 16α-carbonitrile (PCN), a prototypical activator for rodent PXR, in concanavalin A (Con A)-induced liver injury, a model of immune-mediated liver injury, using wild-type and Pxr−/− mice. Unexpectedly, pretreatment with PCN significantly ameliorated Con A-induced liver injury in not only wild-type but Pxr−/− mice as well, accompanied with lowered plasma ALT levels and histological improvements. Pretreatment with PCN was found to significantly repress the induction of Cxcl2 and Ccl2 mRNA expression and neutrophil infiltration into the liver of both wild-type and Pxr−/− mice at the early time point of Con A-induced liver injury. Our results indicate that PCN has unexpected immunosuppressive activity independent of PXR activation to protect mice from immune-mediated liver injury induced by Con A.

KW - Immune-mediated liver injury

KW - Pregnane X receptor

KW - Pregnenolone 16α-carbonitrile

UR - http://www.scopus.com/inward/record.url?scp=85014681755&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85014681755&partnerID=8YFLogxK

U2 - 10.1016/j.toxlet.2017.02.018

DO - 10.1016/j.toxlet.2017.02.018

M3 - Article

VL - 271

SP - 58

EP - 65

JO - Toxicology Letters

JF - Toxicology Letters

SN - 0378-4274

ER -